- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03709251
High Intensity Walking to Reduce Frailty
March 2, 2021 updated by: Margaret Danilovich, Northwestern University
The purpose of this study is to evaluate a physical therapist (PT) led gait training intervention for 100 older adults with pre-frailty or frailty.
The goals of this study are To determine the effect of gait training intensity on frailty, mobility, physical functioning, and quality of life, as well as balance and healthcare utilization.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Frailty is a leading cause of dependency among older adults, affects up to 60% of older adults, and is associated with an increased risk for falls, hospitalizations, institutionalization, and death.
Exercise is the most widely recommended treatment for improving physical function among the frailty, but the optimal type or intensity of exercise is unknown.
Walking is a preferred physical activity among older adults, however, there are no clear guidelines on the best intensity of walking to reduce frailty.
The specific goal of this project is to compare a high intensity walking (HIW) intervention (70-80% of heart rate maximum) to a moderate intensity walking (MIW) intervention (50-60% of heart rate maximum) for pre-frail or frail older adults to determine the impact on frailty, mobility, balance, quality of life, and healthcare utilization.
Study Type
Interventional
Enrollment (Actual)
59
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Univiersity Department of Physical Therapy and Human Movement Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Receiving services from CJE SeniorLife
- Pre-frailty or frailty as determined on the SHARE-FI.
- Able to ambulate at least 10 feet with moderate assistance (<50% physical assistance) or less. Participants will be able to use their assistive device (e.g. cane or walker) during sessions.
- > 65 years of age
- Provision of informed consent and clearance for participation as determined by the Exercise and Screening for You (EASY)
Exclusion Criteria:
- Uncontrolled cardiovascular, metabolic, renal, or respiratory disease that limits exercise participation (e.g., previous heart attack within 3 months of enrollment or uncontrolled diabetes)
- Resting blood pressure > 180/110 mmHg.59
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Casual Speed Walking
Self selected pace
|
Moderate intensity (50-60% of Heart Rate maximum)
|
|
Experimental: High Intensity Walking
HIW (70-80% Heart Rate max)
|
Intense walking activity at an intensity of 70-80% of the maximum heart rate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in frailty as measured by the Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)
Time Frame: Baseline, Week 9, Month 6
|
Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI) which assesses fatigue, appetite, weakness, walking difficulties, and low physical activity
|
Baseline, Week 9, Month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improved mobility as measured by gait speed
Time Frame: Baseline, Week 9, Month 6
|
Measures related to overall health and mobility
|
Baseline, Week 9, Month 6
|
|
Improved mobility as measured by 6 Minute Walk Test
Time Frame: Baseline, Week 9, Month 6
|
Measures related to mobility
|
Baseline, Week 9, Month 6
|
|
Improved mobility as measured by Time Up and Go
Time Frame: Baseline, Week 9, Month 6
|
Measures related to mobility
|
Baseline, Week 9, Month 6
|
|
Improved physical function on the Short Physical Performance Battery
Time Frame: Baseline, Week 9, Month 6
|
Provide an overall assessment of functional status and physical performance
|
Baseline, Week 9, Month 6
|
|
Improved balance as measured by the Berg Balance Scale
Time Frame: Baseline, Week 9, Month 6
|
The Berg Balance Scale is a valid and reliable 14 item tool to evaluate static and dynamic balance among older adults.
Minimum Score 0 to Maximum Score 56.
• Score of < 45 indicates individuals may be at greater risk of falling
|
Baseline, Week 9, Month 6
|
|
Monthly self reports of Health Care Utilization
Time Frame: Baseline, Week 9, Month 3, Month 4, Month 5, Month 6
|
Monthly self-reports of number of falls, number of hospitalizations, and number of emergency room visits
|
Baseline, Week 9, Month 3, Month 4, Month 5, Month 6
|
|
Patient Reported Outcomes Measure Information System (PROMIS) Global Health
Time Frame: Baseline, Week 9, Month 6
|
assess subjective measures of physical and mental health, pain, and quality of life
|
Baseline, Week 9, Month 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 12, 2018
Primary Completion (Actual)
February 8, 2021
Study Completion (Actual)
March 2, 2021
Study Registration Dates
First Submitted
October 12, 2018
First Submitted That Met QC Criteria
October 15, 2018
First Posted (Actual)
October 17, 2018
Study Record Updates
Last Update Posted (Actual)
March 4, 2021
Last Update Submitted That Met QC Criteria
March 2, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00205686
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
McMaster UniversityRecruitingFrailty | Frailty Syndrome | Frail Older Adults | Frailty in AgingCanada
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Universidad Francisco de VitoriaActive, not recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric HealthSpain
-
University of IcelandLandspitali University HospitalRecruitingFrailty Syndrome | Elective Surgery | Frailty in Adult SurgeryIceland
-
University of NottinghamRecruitingFrailty | Diet | Systemic Inflammatory Response | Dietary Fiber | Frailty at Older Adults | Pre-FrailtyUnited Kingdom
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Ji Yan Biomedical Co., Ltd.YC Biotech Co., Ltd.Not yet recruiting
-
Maximilian KönigNot yet recruiting
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
Clinical Trials on High Intensity Walking
-
University of ChicagoTerminatedFrailtyUnited States
-
Texas Woman's UniversityTexas Health ResourcesCompletedHeart Failure NYHA Class II | Heart Failure NYHA Class IIIUnited States
-
University of VirginiaCompletedCardiovascular Diseases | Breast Cancer | CardiotoxicityUnited States
-
The University of Hong KongCompletedMild Cognitive ImpairmentHong Kong
-
University of AlbertaAlberta Paraplegic foundationNot yet recruitingSpinal Cord Injuries (SCI)
-
Ottawa Heart Institute Research CorporationActive, not recruitingCoronary Artery DiseaseCanada
-
Cairo UniversityRecruiting
-
Ottawa Heart Institute Research CorporationOntario Ministry of Health and Long Term Care; Heart and Stroke Foundation...CompletedCoronary Artery Disease (CAD)Canada